Climb Bio, Inc.

Healthcare

NASDAQ:CLYM · NASDAQ Global Market

Market Cap $773.21M Beta 0.10 P/E (TTM) -14.7
$11.45 +0.17%

+$0.02 today

52W Low $1.17High $12.48

Vol 1.06M · Avg 0.88M

EPS (TTM) -$0.77Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+854.17%

Period High

$12.22

Period Low

$1.18

Latest

$11.45

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health
TT

Turn Therapeutics Inc.

NASDAQ:TTRX

$178.13M

Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals, Inc.

NASDAQ:ABOS

$137.37M

Spero Therapeutics, Inc.

Spero Therapeutics, Inc.

NASDAQ:SPRO

$130.57M

Agenus Inc.

Agenus Inc.

NASDAQ:AGEN

$122.65M

Anixa Biosciences, Inc.

Anixa Biosciences, Inc.

NASDAQ:ANIX

$88.63M

Entera Bio Ltd.

Entera Bio Ltd.

NASDAQ:ENTX

$59.64M

Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc.

NASDAQ:INO

$58.95M

Seres Therapeutics, Inc.

Seres Therapeutics, Inc.

NASDAQ:MCRB

$58.83M

AC

Actuate Therapeutics Inc

NASDAQ:ACTU

$50.36M

VT

VistaGen Therapeutics, Inc.

VTGN

$22.30M

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.